A group of 30 delegates from global healthcare company Randox Laboratories has this week travelled to the USA, to take part in the world’s largest diagnostics conference – in San Diego, California.
The American Association of Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo, known as the leading event for laboratory medicine worldwide, is attended by over 20,000 delegates from across the globe, and offers Randox the opportunity to showcase their capabilities and to network with leading healthcare professionals and key decision makers.
Launching at this year’s event are a number of innovative and exciting new products, including a test for Acute Kidney Injury, a revolutionary diagnostic for small, dense low density lipoprotein (sLDL), a subtype of LDL cholesterol which is a vital risk marker for cardiovascular disease, and the latest in laboratory quality assurance software.
Chief Scientist at Randox Laboratories, John Lamont, who is heading up the delegation to the US, commented;
“Our very significant investment in research and development means that we have more new tests in development than any other healthcare company in the world. Each year at AACC we are able to bring a wealth of exciting new technologies to the American market, for a range of the world’s pressing health issues in need of the most urgent address. We look forward to showcasing our latest innovations at this year’s AACC conference, and to identifying further potential projects.”
Dr. Peter FitzGerald, Founder and Managing Director of Randox Laboratories, commented;
“We appreciate that post-Brexit there will of course be particular business challenges with regards to international business, but at Randox we will remain committed to developing new health diagnostic technologies in the areas where they are needed most, and to expanding the business in our key markets, such as the US.
“The USA is one of our most important markets and we have been exporting our diagnostic products there since the early 1980s. We will continue to nurture our presence there, the expansion of which will be supported by our soon to be opened facility in Kearneysville, West Virginia, which will enable us to strengthen our position in that market.”
AACC runs from the 30th July – 3rd August at the San Diego Convention Centre. Randox can be found at booth #3839.
For further information about Randox at AACC please contact Randox PR on 028 9445 1016 or email RandoxPR@randox.com
With 111 years of events under its belt, the Antrim Agricultural Show is one of the longest running and most highly regarded of Northern Ireland’s regional agricultural shows.
Now in its 112th year, and with the backing of a new title sponsor in the form of Antrim-headquartered Randox Laboratories, the show has drawn in its largest crowd to date, with thousands of guests turning up for the Randox Antrim Show 2017, held in Shane’s Castle on Saturday 22nd July.
A special guest to this year’s event was Secretary of State for Environment, Food and Rural Affairs, Michael Gove, visiting the Randox Antrim Show to show his support for the local farming community. During his visit to the popular agricultural show, Mr. Gove stopped by the Randox marquee to chat to Managing Director Dr. Peter FitzGerald, and Senior Manager Mark Campbell, about the company’s patented Biochip Array Technology.
With applications in human health, animal health, and food safety, the Biochip has revolutionised the diagnostics industry because it allows multiple tests to be carried out from a single sample on a single testing platform. Of particular interest to the Secretary of State and to the guests in attendance at this year’s Randox Antrim Show, was the Mycotoxin Biochip, capable of detecting all ten of the world’s most prevalent toxins in animal feed.
Stuart Penrose, Global Marketing Manager for the Randox Biochip, commented;
“Not only does the Randox Antrim Show offer us the opportunity to support the local community in which Randox has grown and flourished over the years, but through this partnership we can also offer that very same community the very latest in diagnostic technology to keep their livestock safe, happy, and importantly, healthy. What your animal eats plays a huge role in their health so with Randox Food Diagnostics you can rest assured that what you are giving your livestock is of the highest quality.”
Also on offer in the Randox marquee at the Randox Antrim Show was a free health analysis, conducted by the Randox Health team. Guests to the tent had the opportunity to find out their true body age – determined by weight, height, blood pressure, fat distribution and muscle distribution, among other measurements taken by a member of the team from Randox Health, the world’s most comprehensive and personalised health screening programme.
Designed to determine the status of your current health, but also to map out your future health, Randox Health constantly works to keep your body healthy. Unlike any other health care, Randox Health doesn’t wait until you are sick to make you better. Hundreds of guests at the Randox Antrim Show queued up in their droves to find out more, and so can you. Simply click here.
For more information about the Randox Antrim Show, please contact Randox PR: email email@example.com or phone 028 9442 2413.
Following the launch of its new Chinese market expansion programme in December 2016, global healthcare diagnostics company Randox Laboratories has made significant strides in its business with China, successfully increasing its exports and enabling new business opportunities within the country.
The firm has just returned from a business trip to China to meet new distributors and customers acquired over the last six months, and to train this recently acquired distributor network on Randox’s latest healthcare technologies, with a key focus on the company’s RIQAS programme, the world’s largest External Quality Assessment scheme for laboratories.
Ying Zhu, Sales Manager for Randox Laboratories in China, commented on the success Randox has seen in China over the last six months;
“China is one of our key markets and although our world-leading diagnostic products have been sold there for more than 20 years, we continue to increase our business presence there thanks to increased output from our innovative R&D programmes, and enhanced manufacturing capabilities, including new facilities at the Randox Science Park, our new headquarters in County Antrim. These infrastructural developments have resulted in an increasing range of products which we can now offer to growing and dynamic markets such as China. This increasing range of products coupled with a growing market presence has significantly increased our business penetration and subsequent support to customers.”
Since the launch of the market expansion programme last year Randox has successfully secured distributors across four of the largest provinces of China and has partnered with key hospitals in Guangzhou, Shanghai and Wuhan.
Margaret Fick, RIQAS Scientist added;
“At our most recent training conference in China, in addition to the educational seminars I conducted with my colleagues, we were also delighted to be able to host several of our newly acquired hospital partners, who presented to our audience of current and potential customers on how their laboratories have benefited from our Randox Quality Control products. The use of testimonials from high profile individuals who have experienced the quality, efficiency and reliability of our products is accelerating our growth across China and this is set to continue over the coming months and years.”
For further information about Randox in China please contact Randox PR on 028 9445 1016 or email RandoxPR@randox.com
Over 50 students from Northern Ireland are gearing up to take part in the first annual ‘STEM Challenge’ hosted at the Randox Science Park. The event, held on International Women in Engineering Day, will round off a week in which the global diagnostics company will unveil a number of initiatives to celebrate and promote women in STEM.
The ‘STEM Challenge’ is aimed at tackling the gender divide and skills gap in the science, technology, engineering and maths industry. On average in the UK women make up just 9% of the engineering workforce. Though Randox is bucking the trend with almost 16% of female engineers, it is still keen to challenge itself to encourage more women to view it as a viable career option.
The week kicks off with the launch of a returnership scheme which is being supported by the NI Chamber of Commerce. This was inspired by the experiences of staff members who returned to work after a career break, and meets a growing demand for a modern approach to recruitment. It will challenge society’s misconceptions surrounding career breaks and support both men and women in restarting their careers. As well as supporting individuals, a UK Government report found that increasing the number of women in work by just five per cent could create £750m extra in tax revenue.
Tackling the gender divide from the opposite end of the career ladder will be the focus at the end of the week. Pupils in Years 10 and 11 from the Belfast Model School for Girls and Victoria College will join R&D scientists and engineers at the new state-of-the-art Randox Science Park for a day of interactive sessions and talks to coincide with International Women in Engineering Day, 23rd June.
Welcoming the students and giving the first talk will be the renowned Máire O’Neill. The Professor of Information Security at Queen’s University Belfast and one-time British Female Inventor of the Year is an inspiring role model and passionate advocate for promoting STEM careers to girls.
The company is also hosting an evening to celebrating local role models in its flagship Randox Health clinic in Holywood. Guests will hear from Dorcas Crawford, senior partner at Edwards & Co., and Johann Muldoon, recently named Best Female Architect in Europe. Both women are recognised for their commitment to equality across industry and their own personal achievements in their fields.
Linda Magee, Global Head of HR for Randox said:
“This promises to be a tremendous week but more than that, it has the potential to have long-lasting benefits. We are pleased to be supported by so many inspiring women as well as the NI Chamber of Commerce.
“Randox is an important employer in the UK and also in Donegal. With our expansion plans comes a need to recruit the very best and brightest people. We hope that our schemes and initiatives will engage young people as well as those who are thinking about returning to work.”
For further information contact Randox PR on 028 9445 1016 or email RandoxPR@randox.com
Global healthcare company Randox, which is headquartered in Co Antrim and has key R&D, engineering and manufacturing facilities in both Co Antrim and Co Donegal, has been named in The US-Ireland Top 50 Companies, to be announced today, Friday 16th June, at the New York/New Belfast conference in Manhattan.
With a focus on the transatlantic operations building bridges between the two countries, the awards celebrate those bringing business in Ireland to global heights in the belief that by doing so they are embedding peace for future generations.
The 50 honourees will be announced at a gala event hosted by the Irish Echo, the USA’s largest and most widely read Irish American weekly paper, at Pier A, Harbor House.
The tenth annual celebration will be addressed by Constance Hunter, Chief Economist of KPMG and Daniel Dromm, NYC City Council member and Chair of the Education Committee, and takes place as part of the two-day conference. This prestigious event highlights the progress and prosperity of both cities, and looks optimistically to the future while celebrating our shared past.
Movie makers, scientists, tech companies and engineers have been among those who have received the plaudit in recent years. They have included the all-conquering production company, HBO; leading law firm A&L Goodbody; pioneers in scientific imaging Andor Technology and the New York Stock Exchange.
This year’s US-Ireland Top 50 has proven to be just as illustrious with Randox Laboratories, Northern Property, Norwegian Airlines, and Bank of Ireland as just some of the companies being recognised for their success.
Editor of the Irish Echo, Ray O’Hanlon, who will host Friday’s event, said the awards were an acknowledgment of the unique bonds between the two nations.
“The unmistakable and unbreakable bonds between Ireland and the United States have proven a key element in Ireland’s progression, both in terms of peace and prosperity. Those bonds grow ever stronger when underpinned by economic growth and business relationships. With the Ireland-US Top 50 we acknowledge those companies whose transatlantic operations support that ongoing development and welcome them to this illustrious list of business beacons.”
Dr. Peter FitzGerald, Founder and Managing Director of Randox Laboratories, commented;
“The US is one of our most important markets and we have been exporting our diagnostic products there since the early 1980s. We have seen substantial success in this market and have secured for example, key clinical chemistry analyser contracts in Ivy League Institutions such as Yale University School of Medicine and Harvard University.
“Our diversification into the veterinary, research, forensic and food safety sectors has enabled our operations in the US to expand further still, and due to this increasing demand for Randox innovations, we are developing a new facility in the Greater Washington DC area.
“It is a tribute to the entire Randox team, both in Co Antrim and Co Donegal, that we have been named as one of the US-Ireland Top 50. We hope to serve as an example to other aspiring businesses that success is possible with a unique product offering, a commitment to investment, and making use of the support network available across the United States.”
For further information about the New York New Belfast Conference contact Randox PR on 028 9445 1016 or email RandoxPR@randox.com
Global healthcare firm Randox Laboratories has pledged its commitment to maintaining and developing its business relationships with Europe, as a group of 20 representatives from the diagnostics company have travelled to Greece this week, to take part in one of Europe’s largest diagnostics conference in Athens.
EuroMedLab, which is run by the European Congress of Clinical Chemistry and Laboratory Medicine, is attended by thousands of healthcare professionals from across the globe, and offers Randox the opportunity to showcase their capabilities and to network with key decision makers.
Managing Director of Randox, Dr. Peter FitzGerald, commented on what the company hopes to achieve by attending EuroMedLab;
“We highly value the business we do within the European market and have successfully made a name for ourselves in the diagnostics industry in these countries. We already have a number of key sales offices and distribution centres in the likes of France, Germany, Portugal, Italy, Spain and Poland, but there is so much more we can do. Attending key networking events such as EuroMedLab is vital because it allows us the opportunity to meet with our existing customers and partners, to nurture and develop these relationships, and of course establish new ones.”
At the EuroMedLab conference the delegation team of Randox scientists, business development executives and market researchers will be making a series of announcements and presentations for new products including an innovative stroke diagnostic, newly discovered biomarkers for coronary heart disease risk, and the latest in laboratory quality assurance software.
The team will also present for the first time the Evidence Evolution analyser, a biochip testing platform capable of delivering accurate results from more than 2600 tests an hour including, but not exclusive to, cancer surveillance, fertility, heart, nutritional, digestive and diabetes health.
Dr. FitzGerald continued;
“At Randox we invest up to 16% of our turnover in R&D and we therefore have more new tests in development than any other diagnostics company in the world. This puts us in a very unique position in the market because our new developments, which are focused in areas where they are needed the most, successfully address the most urgent health issues.
“In light of recent political developments, there will of course be particular business challenges in Europe, but at Randox we will maintain our commitment to nurturing our relationships with key business partners in Europe and to seeking new opportunities in international markets such as the US.”
EuroMedLab runs from the 11th – 15th June 2017 at the Megaron Athens International Conference Centre in Athens. Randox can be found at booth #13 in the Skalkotas Hall Foyer.
A female scientist who has been working on the development of a test that diagnoses sepsis is one of the award-winning students in this year’s university placement scheme with Randox Laboratories.
The breakthrough sepsis test is being created by the Randox Molecular Diagnostics team, which Sarah-Louise Morrow from Belfast joined in September. Her innovative work saw her win third place in the Science category at the company’s annual Pinnacle Placement Awards.
Sarah-Louise, a Biochemistry student from Queen’s University Belfast (QUB), said:
“Sepsis is known as the ‘silent killer’, and the faster you can diagnose it the better for the patient. It was so inspiring working with a team here at Randox who are making such valuable contributions to global health and I couldn’t be happier that something I’ve worked on could save lives in the future.”
Now in its 26th year, the Randox placement programme is recognised internationally for providing world-class opportunities for students and graduates – one of the core reasons that the global diagnostics company was established in 1982. Thirty years on, its founder Dr Peter FitzGerald remains as committed as ever to championing new talent and driving innovation.
Between them, this year’s Randox placement students have spearheaded a number of new designs and projects which are being implemented across the company.
Catherine McCooke, a QUB Electrical and Electronic Engineering student designed a new UV radiation exposure detection mechanism; Shannon McKee, a Business Studies student at Ulster University, conducted highly advantageous market research into emerging markets such as Jamaica and Puerto Rico; and Katie Lawther, a QUB Microbiology student introduced a new cellular tissue storage and tracking system.
The title of Randox Placement Student of the Year 2017 went to Robin Walsh, a QUB student from Lisburn who developed a new chemiluminescence signal reagent which is currently being validated and will be shortly released for production.
The 22 year old’s new product delivers significantly positive effects on the chemistry testing carried out by the Randox New Technology team. It increases test output by a factor of three, saving costs and time which ultimately enables the faster delivery of results for patients.
On receiving his award Robin, who studies Chemical Engineering, said;
“The Randox Placement Programme has far exceeded my expectations. My manager and everyone else in my team have been so supportive and encouraging. I worked on high-level projects I wouldn’t have dreamed possible for a placement student to be involved with. I have gained so much experience during my time as I have been able to translate what I’ve learnt in university into a true working environment. I’ve no doubt this experience will set me apart from the competition in the future.”
Congratulating Robin and his fellow placement students, Jolene Jamison, Randox Placement Co-Ordinator said;
“Taking part in a meaningful placement scheme is one of the most important things a student can do. The young people who are selected to join our programme are given the opportunity to carry out ground-breaking research and development, often working with pioneering technologies that are exported globally.
“The scheme is highly valued by the company so it’s important to take time at its end to celebrate our students. We’re very proud of them all – their contributions are going to make a real difference to global health.”
For the first time two of the Randox Placement award winners were selected from the APEX scheme that Randox runs with UU and QUB. This innovative scheme, which enables applicants to submit “video CVS” on social media to showcase their own personalities, includes paid, full-time summer work experience after a student’s first year of studies, a year-long placement, and a full-time job offer upon graduating, should they obtain a 2:1 or above.
Catherine McCooke who won the overall prize in Engineering said:
“After winning a place through the APEX scheme, being awarded the top prize in Engineering at Randox is unbelievable. It’s particularly important to me because I feel very passionately that women should see that there are no barriers to succeeding as an engineer. I’ve worked incredibly hard with some inspiring people, and have felt respected and valued every step of the way.”
The incoming 2017 summer work experience marks the highest intake of APEX students in Randox so far. Anyone interested in applying for the 2018-19 scheme should email firstname.lastname@example.org.
The top students in the Randox Pinnacle Placement Awards 2017 were:
Robin Walsh, Queen’s University Chemical Engineering – New Technology Evaluation Chemistry Team at Randox
Katie Lawther, Queen’s University Microbiology – Monoclonal Development Team at Randox
Sarah-Louise Morrow, Queen’s University Biochemistry – Molecular Diagnostics Team at Randox
Catherine McCooke, Queen’s University Electrical and Electronic Engineering – R&D Engineering Team at Randox
Ruairi Laverty, Queen’s University Mechanical Engineering – R&D Engineering Team at Randox
Adam Fawcett, The Ulster University Electronic Engineering – Engineering Team at Randox
Shannon McKee, The Ulster University Business – Regional Sales Team at Randox
Martin Conway, The Ulster University Marketing – Marketing Team at Randox
Alastair McIlveen, Queen’s University Computer Science – IT Team at Randox
Make sure to follow us on Facebook, Twitter or Instagram to stay up-to-date with the hashtag #WeAreRandox for more Randox staff stories.
For more information about the #WeAreRandox initiative please contact Randox PR by email: email@example.com or phone 028 9442 2413
Alongside Complete Lab Solutions and Eirecomposites Teo from Galway, Westire Technology Teo from Mayo, and the National University of Ireland Galway, Randox Teoranta is taking part in Údarás na Gaeltachta’s third visit to the Irish Chamber, to showcase the business and job opportunities available in the Irish-speaking Gaeltacht.
The event was launched last night with a welcome reception in the prestigious Pyramid Club of Philadelphia, with a number of presentations, seminars and networking opportunities taking place during today’s session at The Union League of Philadelphia.
Senior Manager of Randox Laboratories, Mark Campbell, who is attending the Symposium in Philadelphia, is looking forward to showcasing what Donegal has to offer, meeting potential business partners and finding new investment opportunities;
“It is a great honour and privilege to join Údarás na Gaeltachta on their Trade Mission and to represent businesses within Donegal at the Symposium. Not only do we have key diagnostics capabilities of interest to the US, we also want to let the wider Irish diaspora know that there are world-leading career opportunities on offer in Donegal, including those in the life sciences, engineering and software development industries. Our revolutionary diagnostics simultaneously allow us to partner with like-minded innovators in markets overseas, and to create further employment at home.”
In 2015 Randox Teoranta in Donegal announced an investment of €25 million to extend and develop the R&D and manufacturing facilities of the state-of-the-art biotech facility. The investment in the site will accelerate the development of new products into a wide range of clinical needs, including various cancers, stroke, heart disease and neurodegenerative disorders.
“Interest in Donegal as an exciting place to live and work has grown significantly in recent times. In the past year alone Donegal Airport was voted one of the world’s most scenic airports, and the National Geographic Traveller named Donegal the coolest place on the planet.
“Our Randox site in Dungloe has much to offer the US and we are looking forward to sharing our innovative diagnostic technologies and our world-class careers with the members of the Irish American Business Chamber and Network.”
Mícheál Ó hÉanaigh, Director of Enterprise, Employment and Property, Údarás na Gaeltachta, is heading up the delegation to Philadelphia, and commented;
“Údarás na Gaeltachta are delighted to have the opportunity to showcase all of our Gaeltacht areas at the Irish American Business Chamber and Network Symposium. Our Diaspora are an essential element in attracting business and employment home to Ireland and to our Gaeltacht areas, a lot of which are located in remote and peripheral areas. We are very proud to be able share a platform with and showcase a cross section of our excellent client companies such as Randox who reflect the business success that can be achieved in cooperation with Údarás na Gaeltachta.”
For more information about the American Business Chamber and Network Symposium please contact Randox PR on 028 9445 1016 or email RandoxPR@randox.com
A number of business leaders and MLAs from Northern Ireland took time to meet with members of our Randox team based in China this week.
The group visited China in a bid to develop and nurture business relationships between the two countries, during a trip organised by the Northern Ireland Assembly Business Trust.
The Trust works to forge business relationships between local businesses and parliamentarians in Northern Ireland, offering a unique opportunity for each to better understand the industry in which they operate. The Trust organises educational visits, fellowships, seminars and trips for local businesses and MLAs to encourage participation on issues of mutual interest.
David Hu and Karen Li, members of Team Randox based in China, met with the group made up of MLAs Colin McGrath, Conor Murphy, Danny Kennedy, Clare Bailey, Kellie Armstrong, and Joanne Dobson, Stephen Kelly, Chief Executive of Manufacturing NI, Colin Neill, the head of Pubs of Ulster, and representatives from the Confucius Institute at Ulster University, an organisation which aims to develop academic, cultural, economic and social ties between Northern Ireland and China.
The group’s trip also involved a visit to the Shenyang Party Congress and Department for Commerce, and to the Irish Embassy in Beijing.
Susan Hammond, Randox China Sales Manager, commented;
“As a key market we have for the past 20 years exported to and worked across China, where Randox is a well-known and respected brand within the healthcare landscape. It is our dedication and hard work within this dynamic market, through both our HQ based team in Northern Ireland and our dedicated local team spread across China, that has enabled this. Our success so far drives us in our continued efforts in growth in this market, and our continued investment in introducing new and innovative products to the market.”
David Hu, Business Development Executive at Randox China, commented;
“It was a fantastic occasion meeting with the delegation from Northern Ireland. We work very closely with the team at Randox HQ in County Antrim, and so we relish the opportunity to engage and develop relationships with relevant representatives from Northern Ireland, whether in the political or business sphere. We’re delighted to be able to gain further insight into the relationships that exist between our two prosperous nations and look forward to nurturing these relationships in the future.”
For further information about our team in China, please contact our Randox PR Team.
T: 028 9445 1016
The future of diagnostic healthcare has been unveiled at the Randox Science Park in Antrim, as the company’s annual global distributors’ conference gets underway. Delegates from more than 90 countries are taking part in the world-leading healthcare firm’s three-day event at the Hilton Hotel in Templepatrick.
As well as discussions about developments in reagents and quality control products, participants enjoyed demonstrations of Randox’s patented Biochip Array Technology and its extensive range of analysers from the RX Series.
Melansha Fernando from Alpha and Omega Diagnostics in Sri Lanka said,
“Randox has released so many new products recently that laboratories in my country are increasingly interested in what it can offer. As a result I felt it important to come here to learn more about the new technologies. The truly global nature of the company has been impressed upon me after meeting colleagues from so many different countries – I’m delighted to have been able to take part.”
Speaking at the conference, Dr. Peter Fitzgerald said,
“All exporters are aware of the considerable challenges we must overcome in order to do business in the global market but year on year our teams across the world have helped to drive our success. One of the biggest challenges Randox faces is the one we put to ourselves, to deliver truly transformative technologies and improve health worldwide. We recently celebrated our £1 billionth sale and we now look to build on that achievement and accelerate our rate of growth. All of our profits go straight to either R&D, or the development of our infrastructure, so strong growth is key to our goal of revolutionising diagnostics and saving lives across the world.”
Susan Hammond, Global Reagents Sales Manager said,
“It is a pleasure to see the diversity of our distributors gathered together in one room, and recognize how far we have come as an international company. We dedicated Thursday to focusing on building relationships with our worldwide distributors to ensure that they attain the best product knowledge available. Over 100,000 end users employ Randox products and every second of every day 80 Randox tests are used across the world, and it is vital our distributors are kept up to date with every new development.”
For more information on the Distributors’ Conference contact Amy in our PR Team by calling 028 9445 1016 or email firstname.lastname@example.org